Why Perimenopause Feels So Different for Every Woman. The Answer Is in Your Genes

Perimenopause is often described as a hormonal transition. But emerging science suggests something deeper is happening beneath the surface: a genetic layer that shapes how each woman experiences this phase.

A new mini-review published in Clinics (São Paulo) explores how variations in three critical genes, COMT, FUT2, and MTHFR, influence health outcomes in perimenopausal women. The findings point toward a more personalized understanding of this life stage, where biology is not one-size-fits-all.

The COMT gene plays a central role in breaking down neurotransmitters such as dopamine and estrogen metabolites. Variants in this gene can significantly affect stress response, emotional regulation, and cognitive function. During perimenopause, when hormonal fluctuations are already destabilizing, reduced COMT activity may intensify mood swings, anxiety, and mental fatigue.

FUT2, on the other hand, connects genetics to the gut. This gene influences the composition of the gut microbiome and the absorption of nutrients, particularly vitamin B12. Women with certain FUT2 variants may experience altered microbial diversity and reduced nutrient uptake, contributing to fatigue, immune imbalance, and metabolic challenges.

Then comes MTHFR, one of the most clinically relevant genes in nutritional genomics. It governs folate metabolism and homocysteine regulation, both critical for cardiovascular and neurological health. Reduced MTHFR activity can lead to elevated homocysteine levels, increasing cardiovascular risk at a time when estrogen’s protective effects are declining.

What makes this study particularly compelling is the interaction between these genes. They do not function independently. Instead, they form a network influencing hormone metabolism, detoxification pathways, and nutrient utilization. This interconnected system helps explain why two women with similar lifestyles can experience completely different perimenopausal symptoms.

The review also highlights the growing role of precision medicine. By integrating genetic insights with lifestyle and environmental data, healthcare can move toward highly individualized strategies. Instead of generalized recommendations, interventions can be tailored to each woman’s biological profile.

The takeaway is clear: perimenopause is not just a hormonal shift. It is a genetically modulated transition that requires a more personalized approach to care.

Why This Matters for GeneFit Readers

General advice fails because biology is individual.

During perimenopause, this becomes even more critical.

• If you carry MTHFR variants, standard folic acid may not be effective  
• If you have FUT2 polymorphisms, your gut health and B12 absorption may be compromised  
• If COMT activity is low, your stress response and estrogen metabolism will behave differently  

GeneFit translates this complexity into action:

• Identify your key genetic polymorphisms  
• Personalize your supplementation strategy  
• Optimize nutrition based on your biology  
• Reduce trial-and-error in managing symptoms  

This is not just better health advice. This is precision health tailored to one of the most sensitive phases of a woman’s life.

‍

Reference

Andrade, P., Santamarina, A. B., de Freitas, J. A., Marum, A. B. R. F., & Pessoa, A. F. M. (2024). Personalized nutrition and precision medicine in perimenopausal women: A minireview of genetic polymorphisms COMT, FUT2, and MTHFR. Clinics (São Paulo), 80, 100549. https://doi.org/10.1016/j.clinsp.2024.100549

‍